A number of recent studies investigated the clinical impact of the IL-6 promoter polymorphisms on different major diseases such as chronic obstructive pulmonary disease [3,4], viral infections [5], gout [6], osteoporosis [7], diabetes [8] or allograft survival [9]. Here, IL6 is linked to chronic obstructive pulmonary disease.